- Clear Solutions team
- 4 days ago
- 2 min read
Clear Solutions’ first 16 months of programming focussed on dedicated distributions of oral rehydration solution and zinc (ORSZ) in Kano state, Nigeria. The distributors were community health workers engaged through partnerships with the State and Local Government Primary Healthcare system, facilitated by locally-led NGO partner iDevPro Africa.
These dedicated distributions enabled rapid iteration and adoption of advanced approaches for planning, monitoring and evaluation (eg. leveraging geographic information systems (GIS) mapping data and distributors’ GPS tracks). We also came to appreciate that the “last mile” effort in reaching each household with a single commodity was likely to remain significant as a proportion of overall program cost (with commodity procurement the other major part), even - or especially - with increased scale. We have thus increased focus on “layering” ORSZ provision onto existing healthcare infrastructure to achieve distribution cost efficiencies and leverage networks already operating at scale.

We are therefore thrilled to announce a collaboration with Malaria Consortium, to pilot
integrated delivery of ORSZ through their seasonal malaria chemoprevention (SMC) platform in Chad in the coming months.
Chad suffers a very high rate of child mortality from diarrhoeal diseases, 560 per 100,000 children under-5 in 2021 (per Global Burden of Disease, the West Sub-Saharan Africa regional average being 197). ORS remains highly under-utilised, with MICS 2019 finding all regions of Chad had <30% of under-5 diarrhoea cases treated with ORS, and some regions <10%.
SMC protects young children aged 3-59 months from malaria by administering antimalaria drugs in regular intervals or cycles during the high-transmission rainy season. The pilot will test community distribution of co-packaged ORSZ alongside routine SMC delivery across a whole health district, expecting to reach ~13,000 children under 5 years old.

ORSZ co-packs, one per child under 5, will be handed to caregivers during door-to-door SMC visits by trained community distributors, together with guidance on recognising diarrhoea symptoms, correct use of ORSZ, safe storage, and when to seek further care.
To maximise learning from the pilot, together we are taking a multi-pronged approach to monitoring and evaluation (M&E):
Formative learnings to guide implementation details, eg. informal community discussions. The implementing team will give feedback on the operational impact of co-distribution.
Malaria Consortium’s existing SMC distribution monitoring and coverage assessments will be extended to capture ORSZ data.
Independent quasi-experimental evaluation of the intervention impact on ORS treatment rates will be monitored in the months following the distribution.
Through these M&E activities, we plan to build a solid evidence base to inform decisions on scale-up of this model in future years.
We thank the Malaria Consortium team for their partnership and are excited for the opportunities for large scale impact that this pilot may unlock!